Table 1

Summary of the human MBD polypeptides

Accession No. a)
Name
Search method / databases b)
Domains c)
MBD position d)

P51608
MECP2
a, b, c, d, e, f, g, ac, bc, cc

96–149
Q9UIS9
MBD1
a, b, c, d, e, f, g, ac, bc, cc
zf-CXXC
7–59
Q9UBB5
MBD2
a, b, c, d, e, f, g, ac, bc, cc

151–204
O95983
MBD3
a, b, c, d, e, f, g, ac, bc, cc

8–60
Q9Z2D7
MBD4
a, b, c, d, e, f, g, ac, bc, cc
HhH-GPD
82–135
Q9UIF9
BAZ2A/TIP5
e, f, g
AT_hook, DDT, PHD, bromodomain
526–577
Q9UIF8
BAZ2B
e, f, g
DDT, PHD, bromodomain,
549–600
Q96T68
CLLD8
e, f, g
SET
162–216
Q15047
SETDB1
e, f, g
SET
597–653
Q9P267
KIAA1461
e, f
PWWP
21–79
Q96Q00
KIAA1887
e, f

304–456

a) Accession numbers according to the SwissProt database. b) a = BLASTP, b = TBLASTN, c = TBLASTX, d = PSI-BLAST, e = Pfam, f = Ncbi, g = SSDB, ac = BLASTP in Celera database, bc = TBLASTN in Celera database, cc = TBLASTX in Celera database. c) domain nomenclature according to the Pfam database, all sequences contain an MBD in addition. d) position in amino acid sequence

Roloff et al. BMC Genomics 2003 4:1   doi:10.1186/1471-2164-4-1